{"id":"NCT01412944","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis","officialTitle":"A Randomized, Double-blind, Double Dummy, Multicenter Study to Assess the Safety, Tolerability and Long-term Efficacy of Intravenous (10mg/kg) and Subcutaneous (300mg) Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Who Are Partial Responders to Secukinumab","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12","primaryCompletion":"2013-04","completion":"2013-04","firstPosted":"2011-08-09","resultsPosted":"2015-03-18","lastUpdate":"2015-03-18"},"enrollment":43,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque-type Psoriasis"],"interventions":[{"type":"DRUG","name":"secukinumab 150mg","otherNames":[]},{"type":"DRUG","name":"secukinumab 10mg/kg i.v. regimen","otherNames":[]}],"arms":[{"label":"AIN457 subcutaneous (s.c.)","type":"EXPERIMENTAL"},{"label":"AIN457 I.V.","type":"EXPERIMENTAL"}],"summary":"The study will assess the safety and efficacy of intravenous (10mg/kg) and subcutaneous (300mg) secukinumab in moderate to severe chronic plaque-type psoriasis who are partial responders to secukinumab.","primaryOutcome":{"measure":"Percentage of Participants (Who Achieved a Partial Response Defined as â‰¥ 50% But < 75% Improvement in Psoriasis Area and Severity Index (PASI) After 12 Weeks of Treatment in Study AIN457A2304) With 75% Improvement From Baseline in PASI","timeFrame":"Week 8","effectByArm":[{"arm":"AIN457 Subcutaneous (s.c.)","deltaMin":66.7,"sd":null},{"arm":"AIN457 I.V.","deltaMin":90.5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":27,"countries":["United States","Austria","Canada","France","Germany","India","Japan","Slovakia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":["NASOPHARYNGITIS","PHARYNGITIS","UPPER RESPIRATORY TRACT INFECTION","FOLLICULITIS","INTERTRIGO"]}}